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I have worked with the porcine hemorrhagic shock model, the prob-
lem I noticed is there is a lot of blood sequestration in the spleen. I
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Dr Karl Illig (Rochester, NY). I’d like to start the session by
pointing out that this was a great project, superbly presented, and to
thank you for setting the stage for our first Peripheral Vascular Surgery
Society (PVSS) session quite nicely. An observation to bemade is that
this project is something that you can probably only do in themilitary
now, and I don’t think you can do this kind of study in the civilian
world very easily anymore. This issue remains extremely important, so
thank you for pursuing this. My single question is that of clinical
application. Granted that long-term benefits of basic and animal
research are sometimes delayed, I’d like to know what you see as an
early direct outcome of this research in terms of actual clinical care to
injured civilians and soldiers?
Dr Heather Hancock. Dr Todd Rasmussen, as you know, was
recently deployed to Afghanistan, and like previous deployments,
observed casualties with extremity vascular injuries where temporary
vascular shunts had been placed to restore perfusion at an early point
after injury. And anecdotally in these instances, the injured appeared
to have well-perfused and soft extremities, which seem to improve
their early neuromuscular outcomes. For example, in these instances,
the fasciotomies were able to be closed early in the postoperative
period. So clinically, we see what appears to be a great benefit such as
early muscle sparing and less compartment syndrome if the extremity
can be perfused early after extremity vascular injury.
Dr Eugene Lee (Sacramento, Calif). A question I have, becauseon’t know if you noticed that and whether you needed to do a
plenectomy on these pigs before you actually bled themout. Because
he variability is all over themap. So you bleed them out, it’s all going
o the spleen, you’re not really sure. So could you address that?
DrHancock.We used a hemorrhage method that was based on
computer physiological response model that was utilized by Frankel
n a porcine model in 2007. When one uses a variable rate, total
olume-controlled hemorrhage model without a splenectomy, one
bserves similar physiologic derangements seen in the hemorrhagic
odels where splenectomy is performed. Because this experiment
nvolved a 14-day survival model, we want to avoid laparotomy and
plenectomy, which increases postoperative morbidity and would
ave limited our ability to assess ambulatory function in the postop-
rative setting.
Furthermore, any autotransfusion from the spleen, which did
ccur in this model, would make the reported results a best-case
cenario. What I mean by best-case scenario is that in this model,
emorrhagic shock existed only for 30 minutes, which would be a
hort time inmany clinical scenarios and perhaps there was autotrans-
usion of blood from the spleen. These facts would serve to support
he animals in thismodel perhapsmitigating the full effect of shock on
xtremity ischemia and reperfusion.Wewould surmise that the results
e report here would only be more significant if the spleen was
emoved and this autotransfusion mechanism were taken away. Ad-
itionally, more prolonged periods of shock may make the results
eported here more significant.
